Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,792 | 125 | 99.3% |
| Education | $19.62 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $422.48 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $374.48 | 12 | $0 (2024) |
| Amgen Inc. | $290.46 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $223.44 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $217.29 | 7 | $0 (2024) |
| Lilly USA, LLC | $197.96 | 11 | $0 (2023) |
| ABBVIE INC. | $194.74 | 10 | $0 (2024) |
| PFIZER INC. | $169.65 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $97.81 | 6 | $0 (2023) |
| Dexcom, Inc. | $87.11 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.11 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($190.21) |
| 2023 | $345.40 | 18 | Novo Nordisk Inc ($88.32) |
| 2022 | $402.00 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($59.32) |
| 2021 | $176.98 | 10 | AbbVie Inc. ($93.91) |
| 2020 | $117.15 | 8 | Lilly USA, LLC ($29.98) |
| 2019 | $230.33 | 13 | Abbott Laboratories ($67.47) |
| 2018 | $473.33 | 24 | Janssen Pharmaceuticals, Inc ($152.98) |
| 2017 | $541.14 | 21 | Amgen Inc. ($120.00) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $98.52 | General |
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $67.92 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.29 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $71.86 | General |
| Category: Cardiology | ||||||
| 01/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $71.86 | General |
| Category: Cardiology | ||||||
| 11/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardio-renal | ||||||
| 09/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardio-renal | ||||||
| 08/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: DIABETES | ||||||
| 08/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 06/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 05/24/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Endocrinology | ||||||
| 04/05/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 03/29/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Endocrinology | ||||||
| 03/14/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Neuroscience | ||||||
| 03/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 314 | 499 | $97,040 | $40,813 |
| 2020 | 10 | 556 | 1,045 | $196,322 | $72,148 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 262 | $57,640 | $22,757 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 156 | $23,400 | $9,244 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 65 | 65 | $15,600 | $8,506 | 54.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 16 | 16 | $400.00 | $305.92 | 76.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 201 | 532 | $117,040 | $40,685 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 125 | 274 | $41,035 | $14,597 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 105 | 105 | $25,200 | $12,507 | 49.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 25 | 31 | $3,559 | $1,178 | 33.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 17 | $2,618 | $1,065 | 40.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,080 | $1,019 | 25.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 33 | 33 | $825.00 | $608.32 | 73.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $490.00 | $241.08 | 49.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 16 | $1,200 | $205.33 | 17.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 11 | 11 | $275.00 | $42.00 | 15.3% |
About Jona Gorra, M.D,
Jona Gorra, M.D, is a Internal Medicine healthcare provider based in Georgetown, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619900461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jona Gorra, M.D, has received a total of $2,811 in payments from pharmaceutical and medical device companies, with $525.11 received in 2024. These payments were reported across 126 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,792).
As a Medicare-enrolled provider, Gorra has provided services to 870 Medicare beneficiaries, totaling 1,544 services with total Medicare billing of $112,960. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Georgetown, DE
- Active Since 07/07/2006
- Last Updated 05/05/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619900461
Products in Payments
- JARDIANCE (Drug) $289.46
- Repatha (Biological) $263.72
- XARELTO (Drug) $194.25
- SYMBICORT (Drug) $122.00
- Rybelsus (Drug) $103.70
- UBRELVY (Drug) $101.73
- Dexcom G6 Transmitter (Medical Supply) $87.11
- ELIQUIS (Drug) $84.07
- ENTRESTO (Drug) $77.57
- EMGALITY (Drug) $73.71
- ClosureFast (Device) $73.04
- MOUNJARO (Drug) $70.00
- Proclaim Family of SCS IPGs (Device) $67.47
- Kerendia (Drug) $64.97
- BREZTRI (Drug) $64.19
- VRAYLAR (Drug) $61.76
- Ozempic (Drug) $56.44
- TRADJENTA (Drug) $55.24
- STIOLTO RESPIMAT (Drug) $47.21
- Saxenda (Drug) $41.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Georgetown
Beshara Helou, Md, MD
Internal Medicine — Payments: $237,797
Dr. Fabricio Alarcon, M.d, M.D
Internal Medicine — Payments: $63,477
Mr. Michael Nacol, Md, MD
Internal Medicine — Payments: $13,410
Robert Martin, M.d, M.D
Internal Medicine — Payments: $11,407
Dr. Arturo Dominguez, M.d, M.D
Internal Medicine — Payments: $9,599
Dr. Matthew Birdwhistell, D.o, D.O
Internal Medicine — Payments: $9,532